Cenk Undey | AIChE

Cenk Undey

Executive Director, Process Development
Amgen

Dr. Undey joined Amgen in 2003 and has held positions of increasing responsibility in

Process Development which included providing manufacturing support, continuous

process improvement of commercial products, and technology transfers. He has

formed the Digital Integration and Predictive Technologies in 2013, a corporate group

with a mission to transform Amgen business from data rich to decision smart. His

group’s aim is to improve process and product understanding, process optimization,

reduce process development cycle time hence increasing speed to market with reduced

development costs using Machine Learning, Smart Sensors and Computational

Predictive Technologies. Dr. Undey led the introduction of real-time multivariate

statistical process monitoring technology, Watson intelligent search via Natural

Language Processing and various Process Analytical Technology initiatives resulting in

significant business benefits. Dr. Undey and his team’s work were externally recognized

receiving CIO100 Award in Life Sciences in 2013 for Amgen implementing advanced

data analytical solutions.

Prior to joining Amgen, Dr. Undey has worked at the Illinois Institute of Technology (IIT),

Dept. of Chemical and Biological Engineering in Chicago, IL as a Sr. Postdoctoral

Researcher. He has co-authored and co-edited two books, published in scientific

journals and books in the areas of process systems engineering, PAT, artificial

intelligence, process monitoring, control, supervision, biotechnology and

bioengineering.

He has received his B.Sc., M.Sc. and Ph.D. degrees all in Chemical Engineering from

Istanbul University, Turkey. He also holds an Executive MBA degree from the University

of California, Los Angeles, Anderson School of Management.

Dr. Undey is based in the headquarters in Thousand Oaks, CA, USA.